Search results for “Melanoma-associated antigen” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 97 patents, we discovered top 21 key players by total patent application. Oncogen Corp., Regeneron Pharmaceuticals, Inc., Immatics Biotechnologies GmbH are dominant in this area. They take 56.70% of the total patent filing.
Oncogen Corp.
Washington, United States
Patent: 23
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 21
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 11
Medigene Immunotherapies GmbH
Germany
Patent: 10
Helmholtz Zentrum München
Germany
Patent: 10
Adaptimmune Ltd.
YORK COUNTY, United Kingdom
Patent: 7
Immunocore Ltd.
United Kingdom
Patent: 7
Active Biotech AB
Sweden
Patent: 5
Millennium Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 3
Novartis AG
Basel-Stadt, Switzerland
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 2 patents, we discovered top 2 start-ups by total patent application.
STARTUP
CDR-Life Inc.
ZURICH, Switzerland
Patent: 1
STARTUP
TTC Corp.
Massachusetts, United States
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 40 patents applied in the last 5 years. We discover 6 most active companies in this area. The fast-growing Regeneron Pharmaceuticals, Inc., Immatics Biotechnologies GmbH, CDR-Life Inc. take 82.50% of patent filing during this period.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 21
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 11
STARTUP
CDR-Life Inc.
ZURICH, Switzerland
Patent: 1
St. Jude Children's Research Hospital, Inc.
Tennessee, United States
Patent: 1
Helmholtz Zentrum München
Germany
Patent: 1
Medigene Immunotherapies GmbH
Germany
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 40 patents in last 5 years, we discover 4 new entrants. Regeneron Pharmaceuticals, Inc., Immatics Biotechnologies GmbH, CDR-Life Inc. are the most active new entrants in this area.
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 21
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 11
STARTUP
CDR-Life Inc.
ZURICH, Switzerland
Patent: 1
St. Jude Children's Research Hospital, Inc.
Tennessee, United States
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 22 patents, we discovered top 7 universities and scientific research institutions by total patent application. University of Southern California, Duke University, Emory University are dominant in this area. They take 36.36% of the total patent filing.
University of Southern California
California, United States
Patent: 2
Duke University
North Carolina, United States
Patent: 1
Emory University
Georgia, United States
Patent: 1
Tsinghua University
Beijing Shi, China
Patent: 1
Beijing Normal University
Beijing Shi, China
Patent: 1
New York Medical College
New York, United States
Patent: 1
President & Fellows of Harvard College
Massachusetts, United States
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: